Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Immunology Research|July 2, 2025
Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy ApplicationsSreekumar Balan, Liam O'Brien, Ante Peros, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2017
Targeting Influenza Virus Hemagglutinin to Xcr1+ Dendritic Cells in the Absence of Receptor-Mediated Endocytosis Enhances Protective Antibody ResponsesArnar Gudjonsson, Anna Lysén, Sreekumar Balan, et al.
Cell Reports|August 16, 2018
Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and HeterogeneitySreekumar Balan, Catharina Arnold-Schrauf, Abdenour Abbas, et al.
Cancer Immunology Research|November 9, 2019
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk MelanomaAnna Pavlick, Ana B Blazquez, Marcia Meseck, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Natural Killer Cell Dysfunction In Human Bladder Cancer Is Caused By Tissue-Specific Suppression of SLAMF6 SignalingAdam M Farkas, Dina Youssef, Michelle A Tran, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Targeting neoantigens conserved across organs and species overcomes tumor immune escapeGuillaume Mestrallet, Ross W Ward, Matthew Brown, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2014
Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cellsSreekumar Balan, Vincent Ollion, Nicholas Colletti, et al.
Iscience|July 5, 2022
Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1Nicolas Vabret, Valérie Najburg, Alexander Solovyov, et al.
Nature Immunology|January 21, 2025
Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancerMeriem Belabed, Matthew D Park, Cédric M Blouin, et al.
Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.
Pageof 3